• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

土三七致肝窦阻塞综合征的临床病理特征及诊断——病例报告并文献复习

Clinicopathological characteristics and diagnosis of hepatic sinusoidal obstruction syndrome caused by Tusanqi - Case report and literature review.

作者信息

Tan Youwen, Zheng Sainan

机构信息

Department of Hepatology, Third Hospital of the Zhenjiang Affiliated Jiangsu University, No. 300, Daijiamen, Runzhou Distinct, Zhenjiang 212003, China.

出版信息

Open Med (Wars). 2023 Jun 12;18(1):20230737. doi: 10.1515/med-2023-0737. eCollection 2023.

DOI:10.1515/med-2023-0737
PMID:37333448
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10276616/
Abstract

Tusanqi-induced hepatic sinusoidal obstruction syndrome (HSOS) is caused by exposure to pyrrolizidine alkaloids (PAs) and manifests as abdominal distension, liver pain, ascites, jaundice, and hepatomegaly. Pathologically, hepatic congestion and sinusoidal occlusion are observed in HSOS. We summarized the clinical characteristics of 124 patients with HSOS caused by Tusanqi in China between 1980 and 2019, along with those of 831 patients from seven English case series. The main clinical manifestations of PA-HSOS included abdominal pain, ascites, and jaundice. Common imaging features included characteristic heterogeneous density, slender hepatic veins, and other nonspecific changes. The acute stage is primarily manifested as hepatic sinus congestion and necrosis. Meanwhile, the persistence of hepatic sinus congestion and the onset of perisinusoidal fibrosis were observed during the repair stage. Finally, the persistence of hepatic sinusoidal fibrosis and resultant central hepatic vein occlusion were observed in the chronic stage. The new Nanjing standard for PA-HSOS incorporates the history of PA consumption and imaging features and eliminates weight gain and the serum total bilirubin value. Preliminary clinical validation of the Nanjing standard for PA-HSOS diagnosis revealed a sensitivity and specificity of 95.35 and 100%, respectively.

摘要

土三七所致肝窦阻塞综合征(HSOS)由接触吡咯烷生物碱(PAs)引起,表现为腹胀、肝区疼痛、腹水、黄疸和肝肿大。病理上,HSOS可见肝淤血和肝窦阻塞。我们总结了1980年至2019年间中国124例土三七所致HSOS患者的临床特征,以及来自7个英文病例系列的831例患者的临床特征。PA-HSOS的主要临床表现包括腹痛、腹水和黄疸。常见的影像学特征包括特征性的密度不均、肝静脉纤细及其他非特异性改变。急性期主要表现为肝窦淤血和坏死。同时,修复期可见肝窦淤血持续存在及肝窦周围纤维化的发生。最后,慢性期可见肝窦纤维化持续存在及由此导致的肝中央静脉阻塞。PA-HSOS的新南京标准纳入了PA摄入史和影像学特征,摒弃了体重增加和血清总胆红素值。PA-HSOS诊断南京标准的初步临床验证显示,其敏感性和特异性分别为95.35%和100%。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2793/10276616/551ad3597539/j_med-2023-0737-fig004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2793/10276616/a84ae32485d8/j_med-2023-0737-fig001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2793/10276616/fdd0d310980d/j_med-2023-0737-fig002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2793/10276616/094fec4c4796/j_med-2023-0737-fig003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2793/10276616/551ad3597539/j_med-2023-0737-fig004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2793/10276616/a84ae32485d8/j_med-2023-0737-fig001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2793/10276616/fdd0d310980d/j_med-2023-0737-fig002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2793/10276616/094fec4c4796/j_med-2023-0737-fig003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2793/10276616/551ad3597539/j_med-2023-0737-fig004.jpg

相似文献

1
Clinicopathological characteristics and diagnosis of hepatic sinusoidal obstruction syndrome caused by Tusanqi - Case report and literature review.土三七致肝窦阻塞综合征的临床病理特征及诊断——病例报告并文献复习
Open Med (Wars). 2023 Jun 12;18(1):20230737. doi: 10.1515/med-2023-0737. eCollection 2023.
2
Clinical characteristics, CT signs, and pathological findings of Pyrrolizidine alkaloids-induced sinusoidal obstructive syndrome: a retrospective study.吡咯里西啶生物碱诱导的肝窦阻塞综合征的临床特征、CT表现及病理结果:一项回顾性研究
BMC Gastroenterol. 2020 Feb 4;20(1):30. doi: 10.1186/s12876-020-1180-0.
3
Tusanqi and hepatic sinusoidal obstruction syndrome.土三七和肝窦阻塞综合征。
J Dig Dis. 2014 Mar;15(3):105-7. doi: 10.1111/1751-2980.12112.
4
Validation of the Nanjing Criteria for Diagnosing Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstruction Syndrome.南京诊断吡咯里西啶生物碱所致肝窦阻塞综合征标准的验证
J Clin Transl Hepatol. 2021 Jun 28;9(3):345-352. doi: 10.14218/JCTH.2020.00124. Epub 2021 Mar 31.
5
Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: Pathogenesis, clinical manifestations, diagnosis, treatment, and outcomes.吡咯里西啶生物碱诱导的肝窦阻塞综合征:发病机制、临床表现、诊断、治疗和结局。
World J Gastroenterol. 2019 Jul 28;25(28):3753-3763. doi: 10.3748/wjg.v25.i28.3753.
6
Expert consensus on the clinical management of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome.吡咯里西啶生物碱诱导的肝窦阻塞综合征临床管理专家共识。
J Gastroenterol Hepatol. 2019 Apr;34(4):634-642. doi: 10.1111/jgh.14612. Epub 2019 Feb 21.
7
Definitive diagnosis of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids.吡咯里西啶生物碱所致肝窦阻塞综合征的明确诊断。
J Dig Dis. 2012 Jan;13(1):33-9. doi: 10.1111/j.1751-2980.2011.00552.x.
8
[Clinicopathological analysis of 16 cases of pyrrolizidine alkaloids-associated hepatic sinusoidal obstruction syndrome].16例吡咯里西啶生物碱相关性肝窦阻塞综合征的临床病理分析
Zhonghua Gan Zang Bing Za Zhi. 2020 Apr 20;28(4):332-337. doi: 10.3760/cma.j.cn501113-20190724-00269.
9
Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum.与食用菊三七相关的肝窦阻塞综合征。
J Hepatol. 2011 Apr;54(4):666-73. doi: 10.1016/j.jhep.2010.07.031. Epub 2010 Sep 22.
10
Low molecular weight heparin in the treatment of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome: five case reports.低分子量肝素治疗吡咯里西啶生物碱所致肝窦阻塞综合征:5例报告
J Int Med Res. 2020 Sep;48(9):300060520961916. doi: 10.1177/0300060520961916.

引用本文的文献

1
Radical total gastrectomy for gastric cancer complicated by hepatic sinusoidal obstruction syndrome: a case report.胃癌合并肝窦阻塞综合征的根治性全胃切除术:1例病例报告
Front Med (Lausanne). 2025 May 9;12:1544400. doi: 10.3389/fmed.2025.1544400. eCollection 2025.
2
Drug-induced hepatic sinusoidal obstruction syndrome: current advances and future perspectives.药物性肝窦阻塞综合征:当前进展与未来展望
Arch Toxicol. 2025 Mar;99(3):835-850. doi: 10.1007/s00204-024-03950-9. Epub 2024 Dec 24.

本文引用的文献

1
A TMT-based shotgun proteomics uncovers overexpression of thrombospondin 1 as a contributor in pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome.基于 TMT 的鸟枪法蛋白质组学揭示,血小板反应蛋白 1 的过表达是吡咯里西啶生物碱诱导的肝窦阻塞综合征的一个促成因素。
Arch Toxicol. 2022 Jul;96(7):2003-2019. doi: 10.1007/s00204-022-03281-7. Epub 2022 Mar 31.
2
Gynura segetum-induced liver injury leading to acute liver failure: a case report and literature review.《葛枣猕猴桃致肝损伤致急性肝衰竭:病例报告及文献复习》
BMC Complement Med Ther. 2022 Mar 8;22(1):61. doi: 10.1186/s12906-022-03549-6.
3
Gynura segetum induces hepatic sinusoidal obstruction syndrome in mice by impairing autophagy.
绞股蓝通过损害自噬诱导小鼠肝窦阻塞综合征。
Acta Cir Bras. 2022 Feb 18;36(11):e361104. doi: 10.1590/ACB361104. eCollection 2022.
4
Development of a Drum Tower Severity Scoring (DTSS) system for pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome.建立吡咯里西啶生物碱肝窦阻塞综合征鼓室严重程度评分(DTSS)系统。
Hepatol Int. 2022 Jun;16(3):669-679. doi: 10.1007/s12072-021-10293-5. Epub 2022 Jan 12.
5
Validation of the Nanjing Criteria for Diagnosing Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstruction Syndrome.南京诊断吡咯里西啶生物碱所致肝窦阻塞综合征标准的验证
J Clin Transl Hepatol. 2021 Jun 28;9(3):345-352. doi: 10.14218/JCTH.2020.00124. Epub 2021 Mar 31.
6
Characterization of liver injury induced by a pyrrolizidine alkaloid in rats.吡咯里西啶生物碱致大鼠肝损伤的特征。
Phytomedicine. 2021 Aug;89:153595. doi: 10.1016/j.phymed.2021.153595. Epub 2021 May 16.
7
Metabolism-mediated cytotoxicity and genotoxicity of pyrrolizidine alkaloids.吡咯里西啶生物碱的代谢介导的细胞毒性和遗传毒性。
Arch Toxicol. 2021 Jun;95(6):1917-1942. doi: 10.1007/s00204-021-03060-w. Epub 2021 May 18.
8
Hepatic sinusoidal obstruction syndrome after oral intake of Gynura segetum.口服紫背天葵后发生的肝窦阻塞综合征
Asian J Surg. 2021 Jul;44(7):991-993. doi: 10.1016/j.asjsur.2021.04.015. Epub 2021 Apr 26.
9
Hepatic sinusoidal obstruction syndrome caused by the ingestion of in a patient with alcoholic cirrhosis: a case report.酒精性肝硬化患者因摄入[具体物质未给出]导致肝窦阻塞综合征:一例报告。
J Int Med Res. 2021 Apr;49(4):300060520980649. doi: 10.1177/0300060520980649.
10
Quantitative CT assessment by histogram and volume ratio in pyrrolizidines alkaloids-induced hepatic sinusoidal obstruction syndrome.吡咯里西啶生物碱诱导的肝窦阻塞综合征的直方图和容积比的定量 CT 评估。
Eur J Radiol. 2021 May;138:109632. doi: 10.1016/j.ejrad.2021.109632. Epub 2021 Mar 6.